Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "MIT"

6613 News Found

Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect
Healthcare | June 11, 2026

Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect

Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing


Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Drug Approval | June 11, 2026

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.


AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines


AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions